MRD
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
MRD
May 13, 2024, 13:11 |
Insight
Justin Kaner: To transplant or not to transplant…..
Justin Kaner, Assistant Professor of the Leukemia Program at Weill Cornell, shared on X: "To…
May 11, 2024, 13:41 |
Blog
Jorge Reis-Filho: A great opportunity to learn more about the exciting work being done at AstraZeneca
Jorge Reis-Filho, Vice President, Cancer Biomarker Development at AstraZeneca, shared a post by Diana Merino…
May 7, 2024, 15:08 |
Blog
Stephen Liu: Dr. Yi-Long Wu discusses adjuvant EGFR targeted therapy at RomeLung24
Stephen Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University, shared on X/Twitter: "Dr.…
May 6, 2024, 08:34 |
Insight
Manni Mohyuddin: Ten important observations about myeloma
Manni Mohyuddin shared a thread on X: . "Ten important observations about myeloma and its…
Apr 30, 2024, 07:31 |
Insight
Top 5 posts of the week by Cancer Network
Cancer Network shared on their X/Twitter page: "View our top 5 posts of the week:…
Apr 29, 2024, 16:55 |
Blog
Nita Radhakrishnan: Wonderful talk by Dr. Anil Handoo
Nita Radhakrishnan shared a post on X: “Multiple signs for hematogones while evaluating Minimal residual…
Apr 26, 2024, 14:15 |
Drugs
Carl Ola Landgren: With Minimal Residual Disease (MRD) as an early endpoint for accelerated approval of new multiple myeloma drugs, patients access to new therapies will be much quicker
Apr 18, 2024, 13:58 |
Insight
Ben Derman: Should MRD negativity be accepted as a surrogate endpoint for clinical trials in myeloma
Ben Derman, Assistant Professor at the University of Chicago, shared on X/Twitter: "Should MRD negativity…
Apr 15, 2024, 12:53 |
Opinion
Nikhil C. Munshi: Getting MRD as an endpoint was a great partnership between academia and industry and patient organization
Nikhil C. Munshi, Associate Director of the Jerome Lipper Multiple Myeloma Center at the Dana-Farber…
Feb 23, 2024, 14:39 |
Insight
Manni Mohyuddin: Why striving for MRD negativity at all costs and having MRD as a primary endpoint may not be ideal
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared…
1
2
All:
13
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube